Incidence and Risk Factors for Brown Adipose Tissue Uptake in PET Imaging in Pediatric Patients

J Pediatr Hematol Oncol. 2024 Jan 1;46(1):e60-e64. doi: 10.1097/MPH.0000000000002778. Epub 2023 Oct 31.

Abstract

Background: Positron emission tomography (PET) scans are used in disease diagnosis and evaluation for pediatric oncology patients. Brown adipose tissue (BAT) 18 F-fluorodeoxyglucose-PET uptake is reported in 35% to 47% of pediatric patients. Several risk factors may be associated with BAT uptake.

Objective: The aim was to determine the incidence and risk factors for BAT in pediatric patients using a consensus-based system and a novel grading scale.

Methods: A total of 285 PET scans in 154 patients were retrospectively reviewed for the presence of BAT from September 2015 through December 2016. A consensus review was done by 2 radiologists, who graded BAT on a 0 to 3 scale and assessed its impact on PET interpretation.

Results: The presence of moderate to severe BAT occurred in 11% of PET scans, and 6% of PETs had limited interpretation. Hodgkin lymphoma (n=53) patients had a 3.62-fold increased odds of moderate or severe BAT and a 6.59-fold increased odds of limited interpretation on PET imaging.

Conclusion: The incidence of BAT was low but impacted radiologic interpretation when present. Further studies with a larger group of Hodgkin lymphoma patients are needed to explore the risk factors associated with moderate or severe BAT.

MeSH terms

  • Adipose Tissue, Brown / diagnostic imaging
  • Child
  • Fluorodeoxyglucose F18
  • Hodgkin Disease*
  • Humans
  • Incidence
  • Positron-Emission Tomography / methods
  • Retrospective Studies
  • Risk Factors

Substances

  • Fluorodeoxyglucose F18